HLTH — Tema Healthcare AI ETF

HLTH Fund Overview

HLTH — Tema Healthcare AI ETF is a US ETF managed by Tema ETF Trust, categorised as Developed ex-US Growth Thematic Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.

• Type: US ETF
• Manager: Tema ETF Trust
• Category: Developed ex-US Growth Thematic Equity
• Ticker: HLTH
• SEC CIK: 0001944285
• SEC series ID: S000104207
• Share class ID: C000274806

HLTH Investment Objective and Strategy

Tema Healthcare AI ETF describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Tema ETF Trust.

Investment objective

Tema Healthcare AI ETF (the “Fund”) seeks to provide long-term growth.

Principal investment strategy

The Fund is an actively managed exchange-traded fund (“ETF”) that under normal circumstances seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in domestic and foreign, common and preferred stocks of publicly listed companies that the Adviser determines are engaged in applying Artificial Intelligence (“AI”) to the Healthcare industry Healthcare AI companies. The Adviser deems a company to be a "Healthcare AI Company” if: (i) at least 40% of its annual revenue is derived from AI enabled products or services that utilize AI technologies to enable, improve, or transform healthcare-related products, services, or operations (each as further described below); (ii) companies that expect to have 40% or more of their annual revenue in the next 18 to 24 months derived from AI enabled products or services that utilize AI technologies to enable, improve, or transform healthcare-related products, services, or operations, but the company has publicly disclosed that Healthcare AI is a strategic focus of its business.

For purposes of determining whether a company is a "Healthcare AI Company,” the Adviser will evaluate a company’s primary business activities and operations using company press coverage, trade groups, equity and debt offering filings, publications specialized in healthcare and healthcare AI, company disclosures, such as earnings conference calls, company presentations, capital markets days, and external research. Examples of such companies include, but are not limited to: - Biotechnology firms that are using AI tools such as machine learning, computational biology, or data-driven platforms to accelerate therapeutic discovery, clinical trial design, biomarker development, or precision medicine. - Life science and diagnostic companies involved in collecting large multi-omic (involving genomics, proteomics, etc.) data sets upon which AI algorithms can be applied to develop new drugs, se

HLTH Costs and Fees

HLTH costs about $75 per $10,000 invested per year in fund expenses.

• Net expense ratio: 0.75%
• Gross expense ratio: 0.75%

HLTH Debt Constituents

No individual debt constituents are reported in Tema Healthcare AI ETF's latest SEC N-PORT filing.

HLTH Prospectus and SEC Filings

Official Tema Healthcare AI ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.

• Prospectus (485BPOS) — filed 2026-07-14
• Prospectus supplement (497) — filed 2026-07-15

Related Funds

Other Developed ex-US Growth Thematic Equity funds tracked on ABC INVEST:

• SoFi AI Power Grid ETF (AMPZ)

Data Sources

ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.